Request Demo

Last update 08 May 2025

HGFA

Last update 08 May 2025

Basic Info

Synonyms

Hepatocyte growth factor activator, Hepatocyte growth factor activator long chain, Hepatocyte growth factor activator short chain

+ [4]

Introduction

Activates hepatocyte growth factor (HGF) by converting it from a single chain to a heterodimeric form.

Drugs associated with HGFA

VD-5123

Target

HGFA x TMPRSS2 x hepsin

Mechanism

HGFA inhibitors [+2]

Active Org.

Washington University School of Medicine

Originator Org.

Washington University School of Medicine

Active Indication

Neoplasms

Inactive Indication-

Drug Highest PhasePreclinical

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

VD-4162

Target

HGFA x TMPRSS2 x hepsin

Mechanism

HGFA inhibitors [+2]

Active Org.

Washington University School of Medicine

Originator Org.

Washington University School of Medicine

Active Indication

Neoplasms

Inactive Indication-

Drug Highest PhasePreclinical

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

Caramcillin

Target

HGFA x hepsin x matriptase

Mechanism

HGFA inhibitors [+2]

Active Org.-

Originator Org.-

Active Indication-

Inactive Indication

Bacterial Infections

Drug Highest PhasePending

First Approval Ctry. / Loc.-

First Approval Date20 Jan 1800

100 Clinical Results associated with HGFA

100 Translational Medicine associated with HGFA

0 Patents (Medical) associated with HGFA

296

Literatures (Medical) associated with HGFA

01 Jun 2025·IJC Heart & Vasculature

Sex differences in proteomics of cardiovascular disease – Results from the Yale-CMD registry

Article

Author: Liu, Yihan ; Safdar, Basmah ; Wang, Zuoheng ; Testani, Jeffery ; Collins, Sean P

Aims This study assessed sex-specific proteomic profiles by cardiovascular disease (CVD) phenotype (coronary artery disease [CAD] vs coronary microvascular dysfunction [CMD]) and describe their role in sex-specific pathways.METHODSIn a secondary biobank analysis of the Yale-CMD registry, adults with ischemic symptoms who underwent cardiac positron emission test/computed tomography were categorized as a) controls (normal coronary flow reserve (CFR) > 2 without perfusion defect or coronary calcification), b) having CMD (CFR < 2 without defect or calcification), or c) having CAD (known CAD or new perfusion defect). Using proximity extension assays (Olink® Explore 3072), we examined 2944 proteins. Differential protein expression was assessed using linear regression models, adjusting for age, race, body mass index, diabetes, dyslipidemia, hypertension, or smoking.RESULTSOf 190 patients, 91 provided blood samples (mean age, 56 years; 66 %, females; 48 %, controls; 24 %, CAD; 27 %, CMD). Among controls, 15 proteins showed sex differences (5 proteins upregulated in females, 10 in males; false discovery rate [FDR < 0.05]). Upregulated in CAD patients were FSHB in females and INSL3 and EDDM3B in males (FDR < 0.05). Among CMD patients, SCGB3A1 and HGFAC were higher in females; INSL3, SPINT3, EDDM3B, and KLK3 were higher in males (FDR < 0.05). Per pathway analysis, females showed upregulation of immune pathways in CAD and lipid and glucose metabolism pathways in CMD. Males showed upregulated endothelial regulation of blood flow in CAD and increased angiogenesis in CMD.CONCLUSIONSSex differences exist in the proteomic profiles of CAD and CMD patients, highlighting a need for precision medicine.

01 Mar 2025·Journal of Chromatography B

An exploratory SWATH plasma proteomics analysis of phyllodes tumor- a type of female breast tumor

Article

Author: Kaur, Navneet ; Bag, Swarnendu ; Akhter, M D Quasid ; Chitkara, Shivani ; Dwivedi, Munish

OBJECTIVEPhyllodes tumors (PT) are rare fibroepithelial breast tumors with poorly understood molecular pathology. This study intent to identify the potential plasma markers of phyllodes tumors compared to controls using Sequential window acquisition of all theoretical fragment ion spectra-mass spectrometry (SWATH-LC-MS) based proteomics approach.METHODPlasma samples from phyllodes tumor cases and controls underwent SWATH-LC-MS/MS based untargeted proteomics analysis. Proteins with 1.5 fold changes & p < 0.05 in PT cases compared to control were considered for further analysis. Statistical analysis was done by using R 4.3.1 software and proteomics analysis was performed by using Spectronaut Software RESULT & CONCLUSION: Three hundred and nineteen proteins were identified. Amongst them 30 proteins were significantly altered in PT case compared to control. 26 were upregulated and 4 were downregulated. Again Protein-Protein network analysis revealed that 21 proteins were matched with STRING data base and out of 21 proteins 19 were highly connected in the interaction analysis. As per our knowledge, this is the first exploratory study on LC-MS/MS-SWATH based phyllodes tumor proteomics. Different proteins like APMAP, HGFAC,TTR, PNO3 etc., and associated pathways like FCGR3A-mediated IL10 synthesis, arylesterase activity, EMT related Wnt/β-catenin Pathway etc. were significantly altered in Phyllodes tumor cases. Hence. this study will help to find the plausible theranostic markers and druggable targets for the phyllodes tumors in future.

01 Feb 2025·Animal Genetics

Identification of differentially expressed genes and polymorphisms related to intramuscular oleic‐to‐stearic fatty acid ratio in pigs

Article

Author: Castelló, Anna ; Criado‐Mesas, Lourdes ; Ramayo‐Caldas, Yuliaxis ; Passols, Magí ; Folch, Josep M. ; Sánchez, Armand ; Valdés‐Hernández, Jesús

AbstractThe intramuscular oleic‐to‐stearic fatty acid ratio (C18:1n‐9/C18:0) is an important indicator of the biosynthesis and desaturation of fatty acids in muscle. By using an RNA‐Seq approach in muscle samples from 32 BC1_DU (25% Iberian and 75% Duroc) pigs with divergent values (high: H and low: L) of C18:1n‐9/C18:0 fatty acids ratio, a total of 81 differentially expressed genes (DEGs) were identified. Functional analyses of DEGs indicate that mainly peroxisome proliferator‐activated receptor signaling pathway (associated genes: PPARG, SCD, PLIN1, and FABP3) was overrepresented. Notably, SCD is directly involved in the conversion of C18:0 to C18:1n‐9, and PPARG is a transcription factor regulating lipid metabolism genes, including SCD. However, other DEGs (e.g., ACADVL, FADS3, EPHB2, HGFAC, NGFR, NR0B2, MDH1, MMAA, PPP1R1B, SFRP5, RAB30, and TRARG1) are plausible candidate genes to explain the phenotypic differences of the C18:1n‐9/C18:0 ratio. Interestingly, seven genetic variants within the SCD (including the well‐known AY487830:g.2228T>C SNP and other novel genotyped polymorphisms) are associated with two haplotypes. Although the haplotypes are segregating at different frequencies in the H and L groups, they do not fully explain the desaturation ratios or the SCD expression levels. A more complex model, including polyunsaturated fatty acids such as C18:2n‐6, C20:4n‐6, and C18:3n‐3, is suggested to explain the regulation of the C18:1n‐9/C18:0 desaturation ratio in porcine muscle.

Analysis

Perform a panoramic analysis of this field.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

HGFA

Basic Info

Related

Analysis